NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank35
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P35
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025-6.56%
Q3 2025-306.67%
Q2 202555.88%
Q1 202565.31%
Q4 2024-444.44%
Q3 202456.10%
Q2 202461.32%
Q1 2024-103.85%
Q4 20237.14%
Q3 2023-30.23%
Q2 20238.51%
Q1 202378.64%
Q4 202290.51%
Q3 2022-3192.00%
Q2 20220.00%
Q1 2022143.35%
Q4 2021-110.98%
Q3 2021-90.70%
Q2 20210.00%
Q1 2021-22731.58%
Q4 2020111.38%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%